TrialCancer discovery2022

Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket Study.

Claire F Friedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.